Written Question · S5W-05450 · Session 5
What its response is to reported concerns that some people with diabetes are unable to access continuous glucose monitoring through the NHS.
The question
To ask the Scottish Government what its response is to reported concerns that some people with diabetes are unable to access continuous glucose monitoring through the NHS.
The answer
Scottish Government works closely with the Scottish Diabetes Group, our national advisory group, to oversee and drive implementation of our Diabetes Improvement Plan (2014) to improve care and treatment for people living with diabetes in Scotland. The Plan includes a range of actions that aim to support improvements in glycaemic control, including the development of a national approach to the provision of Continuous Glucose Monitoring (CGM).
Our national approach has been developed taking account of the clinical evidence which recommends the use of CGM devices for a small number of people with diabetes as an aid to improve glycaemic control, but does not recommend CGM for routine use. Clinicians are best placed to provide specific advice and support to individuals, based on their circumstances, which can include the provision of CGM where a clinical need for one is identified. The national approach will support clinicians in the provision of this technology and ensure that those who would clinically benefit from it can receive it.
To support this, we are investing over £10m over the term of the Parliament, to increase the provision of insulin pump therapy and CGM.
Our national approach has been developed taking account of the clinical evidence which recommends the use of CGM devices for a small number of people with diabetes as an aid to improve glycaemic control, but does not recommend CGM for routine use. Clinicians are best placed to provide specific advice and support to individuals, based on their circumstances, which can include the provision of CGM where a clinical need for one is identified. The national approach will support clinicians in the provision of this technology and ensure that those who would clinically benefit from it can receive it.
To support this, we are investing over £10m over the term of the Parliament, to increase the provision of insulin pump therapy and CGM.
In the Official Report
No contribution in the Official Report cites S5W-05450 by reference.